Lung Bioreactor Pressure Control for Functional Airway Maturation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The long wait times and high mortality rates associated with lung transplants due to the unavailability of suitable donor organs necessitate the development of bioreactors that can generate and preserve functional lung tissue for transplantation.

Innovation Solution

The use of lung bioreactors equipped with an organ chamber, ingress and egress lines, a controller, and pressure sensors to facilitate fluid exchange and maturation of lung tissue through wet or dry ventilation, ensuring minimal tracheal pressure fluctuation and maintaining a constant fluid level, thereby producing functional lung organs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If lung transplants are performed using donor organs, then patients can receive life-saving treatment, but wait times exceed two years and mortality rate reaches 30%

Engineering Contradiction:
Improvetransplant success rateVSAvoidwait time for transplant
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by maturing lung tissue in bioreactors before transplantation. The tissue is prepared in advance through controlled culture processes, allowing it to reach functional maturity prior to implantation. This eliminates the need to wait for donor organs and significantly reduces transplant wait times while maintaining high success rates.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If bioreactors are used to generate lung tissue, then wait time is reduced and functional organs can be produced, but device complexity increases

Engineering Contradiction:
Improveorgan generation rateVSAvoidbioreactor system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The bioreactor system is segmented into modular components including organ chambers, reservoir systems, and control units. Each module performs a specific function (e.g., tissue culture, fluid storage, parameter monitoring) and can be independently optimized or replaced. This modular architecture manages system complexity while maintaining high productivity in organ generation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The bioreactor system is designed with multi-functional components that can perform multiple operations. For example, the same apparatus can culture different types of tissue, perform both wet and dry ventilation, and integrate monitoring and control functions. This universality reduces the need for multiple specialized devices, managing overall system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Speed

If fluid exchange is increased to accelerate tissue maturation, then organ development speed increases, but tracheal pressure fluctuation increases

Engineering Contradiction:
Improvetissue maturation speedVSAvoidtracheal pressure fluctuation
Core Design Contradiction:
SpeedVSStress or pressure

Solution Approach 1:

The system incorporates feedback control through pressure sensors that continuously monitor tracheal pressure during fluid exchange. When pressure fluctuations exceed predetermined thresholds, the control system automatically adjusts fluid flow rates and exchange parameters. This feedback mechanism maintains rapid tissue maturation while keeping pressure fluctuations within safe physiological limits.

Inventive Principle:
Principle #23Feedback

4Reliability

If wet ventilation is used to promote tissue maturation, then organ development is enhanced, but fluid level stability becomes critical

Engineering Contradiction:
Improvetissue maturation qualityVSAvoidfluid level stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The bioreactor system incorporates self-regulating mechanisms for fluid level maintenance. Level sensors detect fluid height in real-time and automatically trigger refilling or drainage operations to maintain optimal levels. This self-service approach ensures continuous stable fluid levels during wet ventilation, supporting reliable tissue maturation without manual intervention.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20260008982A1Lung bioreactor
Publication Date: 2026.01.08 THE GENERAL HOSPITAL CORP
  • US20260008982A1 patent drawing
  • US20260008982A1 patent drawing
  • US20260008982A1 patent drawing

AI summary

Presented is an airway organ bioreactor apparatus, and methods of use thereof, as well as bioartificial airway organs produced using the methods, and methods of treating subjects using the bioartificial airway organs. The bioreactor comprises: an organ chamber: an ingres line connecting the organ chamber and a reservoir system and comprising an arterial line, a venous line and a tracheal line; an egress line connecting the chamber and the reservoir system, pumps in ingress and egress lines; a controller to control fluid exchange; a chamber pressure sensor connected to the organ chamber.